- Home
- SYRE vs GES Comparison
SYRE vs GES Comparison
Compare SYRE & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- GES
- Stock Information
- Founded
- SYRE 2013
- GES 1981
- Country
- SYRE United States
- GES Switzerland
- Employees
- SYRE N/A
- GES N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- GES Apparel
- Sector
- SYRE Health Care
- GES Consumer Discretionary
- Exchange
- SYRE Nasdaq
- GES Nasdaq
- Market Cap
- SYRE 1.1B
- GES 872.4M
- IPO Year
- SYRE 2016
- GES 1996
- Fundamental
- Price
- SYRE $23.56
- GES $16.93
- Analyst Decision
- SYRE Strong Buy
- GES Buy
- Analyst Count
- SYRE 6
- GES 5
- Target Price
- SYRE $57.60
- GES $19.25
- AVG Volume (30 Days)
- SYRE 1.3M
- GES 626.2K
- Earning Date
- SYRE 11-06-2025
- GES 11-25-2025
- Dividend Yield
- SYRE N/A
- GES 5.31%
- EPS Growth
- SYRE N/A
- GES N/A
- EPS
- SYRE N/A
- GES 0.35
- Revenue
- SYRE N/A
- GES $3,091,508,000.00
- Revenue This Year
- SYRE N/A
- GES $7.97
- Revenue Next Year
- SYRE N/A
- GES $3.46
- P/E Ratio
- SYRE N/A
- GES $48.87
- Revenue Growth
- SYRE N/A
- GES 7.84
- 52 Week Low
- SYRE $10.91
- GES $8.48
- 52 Week High
- SYRE $40.26
- GES $18.08
- Technical
- Relative Strength Index (RSI)
- SYRE 70.08
- GES 66.58
- Support Level
- SYRE $21.88
- GES $16.75
- Resistance Level
- SYRE $24.02
- GES $16.89
- Average True Range (ATR)
- SYRE 1.62
- GES 0.09
- MACD
- SYRE 0.32
- GES -0.05
- Stochastic Oscillator
- SYRE 93.11
- GES 95.00
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.